Genetic research
Researchers from the Tianjin University of Science and Technology have developed a novel lung-targeted cancer gene therapy using docetaxel and TUBB3-siRNA-loaded lipid nanoparticles. This innovative formulation addresses the need for specialized treatments with strong lung targeting capabilities, currently lacking in the field. The study's findings suggest that the
Genetic research
Researchers at the University of California Santa Barbara have made significant advancements in cancer gene therapy using multivalent lipid micellar nanoparticles. According to a recent study published in ACS Applied Nano Materials, these nanoparticles exhibit increased paclitaxel loading with pegylation enhancing cancer cell penetration and cytotoxicity. Key Takeaways: * The study
Cancer research
Researchers from Idaho State University have made significant breakthroughs in cancer gene therapy, leveraging a liposomal delivery system to enhance the pharmacokinetics of Jaspine B, a synthetic analog of anhydrophytosphingosine. This innovative approach has demonstrated improved therapeutic outcomes, with the liposomal formulation accelerating the absorption of Jaspine B and prolonging
Cancer research
Pancreatic cancer, one of the most formidable malignancies, has seen minimal improvement in survival rates despite advances in chemotherapy, targeted treatments, and radiation therapy. However, the rapid discovery of the genetic and molecular functions underlying pancreatic cancer has led to new opportunities for targeted therapies, including oncolytic viral therapy. This
Genetic research
Researchers at Ningbo University have made a groundbreaking discovery in the field of cancer research, identifying 18 Myb gene family members in the economically important red alga Gracilariopsis lemaneiformis. The study, published in Marine Biotechnology, reveals that these genes play a crucial role in high-temperature stress, salicylic acid, methyl jasmonate,
Cancer research
A new study has found that incorporating a 70-gene signature (70-GS) into a well-validated breast cancer model, PREDICT, can improve its ability to estimate breast cancer prognosis, potentially reducing overtreatment and its long-term impact on patients' quality of life. The study used data from the MINDACT trial and the
Cancer research
Current research out of Flinders University has yielded promising results in the treatment of multiple myeloma (MM), an incurable malignancy of plasma cells. According to the study, ferroptosis, a recently characterized form of non-apoptotic programmed cell death, may hold the key to novel treatment strategies. The research demonstrated a strong
Cancer
A team of researchers from the University of Oxford and Nanyang Technological University, Singapore (NTU Singapore) has made a groundbreaking discovery in the field of DNA repair, revealing the mechanism by which cells identify and repair highly toxic DNA damage that causes cancer, neurodegeneration, and premature ageing. The study, published
Cancer
Research conducted by scientists from Nanjing Medical University has made significant strides in understanding the relationship between aberrant DNA methylation and gastric cancer prognosis. Leveraging multi-omics data from various databases, including The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx) Project, and Gene Expression Omnibus (GEO) database, the study aimed to
Cancer research
Researchers at Capital Medical University in Beijing, People's Republic of China, have made a significant discovery in the field of colon cancer diagnosis. According to the study, a multivariate prediction method has been developed to improve the diagnostic accuracy of colorectal cancer. The research team, led by Junyue
Cancer research
Researchers have made new findings on the pathogenesis of human papillomavirus (HPV) and recurrent respiratory papillomatosis (RRP) caused by HPV6/11, and the current treatments and potential new foundations for development of future treatments. The study's findings are based on a comprehensive literature search using PubMed and Google
Cancer research
A clinical trial, led by UNICANCER and in collaboration with the University of Warwick, aims to determine the effectiveness of a genetic test, Prosigna, in deciding whether to administer chemotherapy to premenopausal women with hormone-dependent breast cancer. The trial seeks to assess whether optimized hormonal treatment, including ovarian suppression, can
